Cover Image
市場調查報告書

免疫檢測的全球市場預測 2021年:ELISA,快速診斷,Western印跡,ELISPOT,輻射免疫檢測 (RIA) 、PCR

Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, Software, Services), Technique (ELISA, Rapid Test), Application (Infectious Diseases, Endocrinology, Oncology), End User (Clinical Labs, Hospitals) - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 289163
出版日期 內容資訊 英文 208 Pages
訂單完成後即時交付
價格
Back to Top
免疫檢測的全球市場預測 2021年:ELISA,快速診斷,Western印跡,ELISPOT,輻射免疫檢測 (RIA) 、PCR Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, Software, Services), Technique (ELISA, Rapid Test), Application (Infectious Diseases, Endocrinology, Oncology), End User (Clinical Labs, Hospitals) - Global Forecast to 2021
出版日期: 2016年11月17日 內容資訊: 英文 208 Pages
簡介

免疫檢測的市場規模,預計從2016年的171億6,000萬美元,到2021年的254億5,000萬美元,以8.2%的年複合成長率擴大。慢性疾病的發病率增加,癌症的免疫檢測的廣泛利用,技術進步,成本效率及快速的分析,對該市場的成長有所貢獻。

本報告提供全球免疫檢測市場相關調查,市場基本結構和最新趨勢,主要市場促進、阻礙因素,市場規模趨勢預測,各技術、產品和服務、用途、終端用戶及各地區詳細趨勢,市場競爭的狀態,主要企業簡介等調查、考察。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 免疫檢測市場在穩定的成長率的成長預計
  • 地區分析:全球免疫檢測市場,各產品與服務
  • 全球免疫檢測市場:各技術
  • 全球免疫檢測市場地區概述
  • 全球免疫檢測市場:各用途
  • 全球免疫檢測市場:各終端用戶
  • 生命週期分析:各地區

第5章 免疫檢測的全球市場:概要

  • 簡介
  • 市場動態
    • 促進要素、阻礙要素、機會、課題
    • 促進要素
    • 阻礙要素
    • 機會
    • 課題

第6章 免疫檢測的全球市場:各技術

  • 簡介
  • 酵素結合免疫吸附檢測法 (ELIZA)
    • 各平台
    • 各類型
  • 快速診斷
  • Western印跡
  • ELISPOT
  • 輻射免疫檢測 (RIA)
  • 聚合酵素鏈鎖反應 (PCR)

第7章 免疫檢測的全球市場:各產品與服務

  • 簡介
  • 試劑 & 套件
    • 各類型
  • 分析儀
    • 各購買形態
    • 各類型
  • 軟體、服務

第8章 免疫檢測的全球市場:各用途

  • 簡介
  • 感染疾病
  • 內分泌學
  • 骨&礦物質代謝障礙
  • 癌症
  • 心血管
  • 血液學、血液篩檢
  • 自體免疫疾病
  • 毒物學
  • 新生兒篩檢
  • 其他

第9章 免疫檢測的全球市場:各終端用戶

  • 簡介
  • 醫院
  • 臨床檢驗室
  • 血庫
  • 大學研究中心
  • 醫藥品企業、CRO、生物科技企業
  • 其他終端用戶

第10章 免疫檢測的全球市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他的歐洲 (ROE)
  • 亞洲
    • 日本
    • 中國
    • 印度
    • 韓國
    • 台灣
    • 其他亞洲 (ROA)
  • 其他 (ROW)

第11章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭情形、趨勢

第12章 企業簡介

  • 簡介
  • F. HOFFMANN-LA ROCHE LTD.
  • BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION)
  • BIO-RAD LABORATORIES, INC.
  • SIEMENS AG
  • SYSMEX CORPORATION
  • BIOMERIEUX SA
  • ALERE INC.
  • BECTON, DICKINSON AND COMPANY
  • ORTHO CLINICAL DIAGNOSTICS, INC.
  • ABBOTT LABORATORIES, INC.

第13章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 4751

The immunoassay market is expected to reach USD 25.45 billion by 2021 from USD 17.16 billion in 2016 at a CAGR of 8.2%. The global immunoassay market is segmented based on product & service, technology, application, end user, and region. The reagents & kits segment is expected to account for the largest market share of the immunoassay market during the forecast period. The high growth in this segment can be attributed to the expanding use of immunoassay tests worldwide.

On the basis of technology, the ELISA segment is expected to account for the largest share of the market in 2016. Expanding use of immunoassay tests in cancer, point-of-care in vitro diagnostics, infectious disease testing, and therapeutic drug level monitoring as well as the introduction of novel biomarkers will drive the growth of this market.

On the basis of application, the market is segmented into infectious diseases, endocrinology, bone and mineral disorders, oncology, cardiology, hematology and blood screening, autoimmune diseases, toxicology, neonatal screening, and other applications. The rise in incidence of HIV, tuberculosis, hepatitis, and other hospital-acquired infections has fueled the demand for immunoassay tests in the infectious diseases segment.

Geographically, the immunoassay market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American region is primarily driven by rapidly increasing aging population and the concomitant rise in the prevalence of diseases as well as the growing life expectancy.

The major factors contributing to the growth of the immunoassay market include rising incidences of chronic diseases, extensive use of immunoassays in oncology, technological advancements, cost-effectiveness & rapid analysis of immunoassays.

The major players in this market include F. Hoffmann-La Roche Ltd. (Switzerland), Siemens AG (Germany), Abbott Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Ortho-Clinical Diagnostics, Inc. (U.S.), and bioMerieux SA (France).

Research Coverage:

Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The abovementioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful in the immunoassay market.

Reasons to Buy the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the immunoassay market. The report analyses the immunoassay market by product & service, technology, application, end user, and region
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the immunoassay market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the immunoassay market
  • Market Development: Comprehensive information about emerging markets. This report analyses the market for various immunoassay products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the immunoassay market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. SECONDARY DATA
    • 2.1.1. KEY DATA FROM SECONDARY SOURCES
  • 2.2. PRIMARY DATA
    • 2.2.1. KEY DATA FROM PRIMARY SOURCES
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. THE IMMUNOASSAY MARKET IS PROJECTED TO GROW AT A ROBUST GROWTH RATE FROM 2016 TO 2021
  • 4.2. GEOGRAPHIC ANALYSIS: GLOBAL IMMUNOASSAY MARKET, BY PRODUCT AND SERVICE
  • 4.3. GLOBAL IMMUNOASSAY MARKET, BY TECHNOLOGY
  • 4.4. GEOGRAPHICAL SNAPSHOT OF THE GLOBAL IMMUNOASSAY MARKET
  • 4.5. GLOBAL IMMUNOASSAY MARKET, BY APPLICATION
  • 4.6. GLOBAL IMMUNOASSAY MARKET, BY END USER
  • 4.7. LIFECYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. IMMUNOASSAY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES 38

    • 5.2.2. DRIVERS
      • 5.2.2.1. Growing Prevalence of Infectious and Chronic Diseases
      • 5.2.2.2. Extensive Use of Immunoassays in Oncology
      • 5.2.2.3. Technological Advancements
      • 5.2.2.4. Cost-effectiveness & Rapid Analysis
      • 5.2.2.5. Growth in the Biotechnology and Pharmaceutical Sector
    • 5.2.3. RESTRAINTS
      • 5.2.3.1. Low Detection Limit of Immunoassays
      • 5.2.3.2. Implementation of Excise Duty By the U.S. Government
      • 5.2.3.3. Stringent Regulations
    • 5.2.4. OPPORTUNITIES
      • 5.2.4.1. Integration of Microfluidics in Immunoassays
      • 5.2.4.2. Point-of-care Testing with Multiplex Assay
      • 5.2.4.3. Emerging Economies
    • 5.2.5. CHALLENGES
      • 5.2.5.1. Pricing Pressure on Manufacturers

6. IMMUNOASSAY MARKET, BY TECHNOLOGY

  • 6.1. INTRODUCTION
  • 6.2. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
    • 6.2.1. ELISA MARKET, BY PLATFORM
      • 6.2.1.1. Chemiluminescence Immunoassays (CLIA)
      • 6.2.1.2. Fluorescence Immunoassays (FIA)
      • 6.2.1.3. Colorimetric Immunoassay (CI)
    • 6.2.2. ELISA MARKET, BY TYPE
      • 6.2.2.1. First Generation
      • 6.2.2.2. Second Generation
      • 6.2.2.3. Third Generation
      • 6.2.2.4. Fourth Generation and above
  • 6.3. RAPID TESTS
  • 6.4. WESTERN BLOT
  • 6.5. ELISPOT
  • 6.6. RADIOIMMUNOASSAYS (RIA)
  • 6.7. POLYMERASE CHAIN REACTION (PCR)

7. IMMUNOASSAY MARKET, BY PRODUCT AND SERVICE

  • 7.1. INTRODUCTION
  • 7.2. REAGENTS & KITS
    • 7.2.1. BY TYPE
      • 7.2.1.1. Enzyme-linked Immunosorbent Assay (ELISA) Reagents and Kits
      • 7.2.1.2. Rapid Test Reagents and Kits
      • 7.2.1.3. Western Blot Reagents and Kits
      • 7.2.1.4. ELISPOT Reagents and kits
      • 7.2.1.5. RIA Reagents and Kits
      • 7.2.1.6. PCR Reagents and Kits
  • 7.3. ANALYZERS
    • 7.3.1. BY PURCHASE MODE
      • 7.3.1.1. Reagent Rental Purchase
      • 7.3.1.2. Outright Purchase
    • 7.3.2. BY TYPE
      • 7.3.2.1. Open-ended systems
      • 7.3.2.2. Closed-ended systems
  • 7.4. SOFTWARE AND SERVICES

8. IMMUNOASSAY MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. INFECTIOUS DISEASES
  • 8.3. ENDOCRINOLOGY
  • 8.4. BONE AND MINERAL DISORDERS
  • 8.5. ONCOLOGY
  • 8.6. CARDIOLOGY
  • 8.7. HEMATOLOGY AND BLOOD SCREENING
  • 8.8. AUTOIMMUNE DISORDERS
  • 8.9. TOXICOLOGY
  • 8.10. NEONATAL SCREENING
  • 8.11. OTHER APPLICATIONS

9. IMMUNOASSAY MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITALS
  • 9.3. CLINICAL LABORATORIES
  • 9.4. BLOOD BANKS
  • 9.5. RESEARCH & ACADEMIC LABORATORIES
  • 9.6. PHARMACEUTICAL COMPANIES, CROS, AND BIOTECHNOLOGY COMPANIES
  • 9.7. OTHER END USERS

10. IMMUNOASSAY MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
    • 10.2.3. MEXICO
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. FRANCE
    • 10.3.3. U.K.
    • 10.3.4. ITALY
    • 10.3.5. SPAIN
    • 10.3.6. REST OF EUROPE (ROE)
  • 10.4. ASIA
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. INDIA
    • 10.4.4. SOUTH KOREA
    • 10.4.5. TAIWAN
    • 10.4.6. REST OF ASIA (ROA)
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. STRATEGIC OVERVIEW
  • 11.3. MARKET SHARE ANALYSIS
  • 11.4. COMPETITIVE SITUATION AND TRENDS
    • 11.4.1. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 11.4.2. REGULATORY APPROVALS
    • 11.4.3. EXPANSIONS
    • 11.4.4. PRODUCT LAUNCHES
    • 11.4.5. ACQUISITIONS

12. COMPANY PROFILES (Overview, Products and Services, Financials, Strategy & Development)*

  • 12.1. INTRODUCTION
  • 12.2. F. HOFFMANN-LA ROCHE LTD.
  • 12.3. BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER CORPORATION)
  • 12.4. BIO-RAD LABORATORIES, INC.
  • 12.5. SIEMENS AG
  • 12.6. SYSMEX CORPORATION
  • 12.7. BIOMERIEUX SA
  • 12.8. ALERE INC.
  • 12.9. BECTON, DICKINSON AND COMPANY
  • 12.10. ORTHO CLINICAL DIAGNOSTICS, INC.
  • 12.11. ABBOTT LABORATORIES, INC.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: INCIDENCE OF INFECTIOUS DISEASES, 2014-2015
  • TABLE 2: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 3: IMMUNOASSAY MARKET SIZE FOR ELISA, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 4: ELISA MARKET SIZE, BY PLATFORM, 2014-2021 (USD MILLION)
  • TABLE 5: ELISA MARKET SIZE, BY GENERATION, 2014-2021 (USD MILLION)
  • TABLE 6: CLIA MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 7: FIA MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 8: COLORIMETRIC IMMUNOASSAYS (CI) MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 9: FIRST-GENERATION ELISA MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 10: SECOND-GENERATION ELISA MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 11: THIRD-GENERATION ELISA MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 12: FOURTH-GENERATION ELISA MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 13: IMMUNOASSAY MARKET SIZE FOR RAPID TESTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 14: IMMUNOASSAY MARKET SIZE FOR WESTERN BLOT, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 15: IMMUNOASSAY MARKET SIZE FOR ELISPOT, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 16: IMMUNOASSAY MARKET SIZE FOR RIA, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: IMMUNOASSAY MARKET SIZE FOR POLYMERASE CHAIN REACTION (PCR), BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 18: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 19: IMMUNOASSAY REAGENTS & KITS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 20: ELISA REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: RAPID TEST REAGENTS AND KITS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: WESTERN BLOT REAGENTS AND KITS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 23: ELISPOT REAGENTS AND KITS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: RIA REAGENTS AND KITS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: PCR REAGENTS AND KITS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 27: IMMUNOASSAY ANALYZERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 28: IMMUNOASSAY ANALYZERS MARKET SIZE, BY PURCHASE MODE, 2014-2021 (USD MILLION)
  • TABLE 29: REAGENT RENTAL PURCHASE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: OUTRIGHT PURCHASE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 31: OPEN-ENDED IMMUNOASSAY SYSTEMS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 32: CLOSED-ENDED IMMUNOASSAY SYSTEMS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 33: IMMUNOASSAY SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 35: IMMUNOASSAY MARKET SIZE FOR INFECTIOUS DISEASES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 36: IMMUNOASSAY MARKET SIZE FOR ENDOCRINOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: IMMUNOASSAY MARKET SIZE FOR BONE AND MINERAL DISORDERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: IMMUNOASSAY MARKET SIZE FOR ONCOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 39: IMMUNOASSAY MARKET SIZE FOR CARDIOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 40: IMMUNOASSAY MARKET SIZE FOR HEMATOLOGY AND BLOOD SCREENING, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 41: PREVALENCE OF AUTOIMMUNE DISEASES
  • TABLE 42: IMMUNOASSAY MARKET SIZE FOR AUTOIMMUNE DISORDERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: IMMUNOASSAY MARKET SIZE FOR TOXICOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: IMMUNOASSAY MARKET SIZE FOR NEONATAL SCREENING, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 45: IMMUNOASSAY MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 46: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 47: IMMUNOASSAY MARKET SIZE FOR HOSPITALS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 48: IMMUNOASSAY MARKET SIZE FOR CLINICAL LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 49: IMMUNOASSAY MARKET SIZE FOR BLOOD BANKS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 50: IMMUNOASSAY MARKET SIZE FOR RESEARCH & ACADEMIC LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: IMMUNOASSAY MARKET SIZE FOR PHARMACEUTICAL COMPANIES, CROS, AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 52: IMMUNOASSAY MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 53: IMMUNOASSAY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 54: NORTH AMERICA: IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 55: EUROPE: IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 56: ASIA: IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 57: NORTH AMERICA: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 58: NORTH AMERICA: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 59: NORTH AMERICA: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 60: NORTH AMERICA: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 61: U.S.: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 62: U.S.: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 63: U.S.: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 64: U.S.: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 65: CANADA: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 66: CANADA: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 67: CANADA: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 68: CANADA: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 69: MEXICO: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 70: MEXICO: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 71: MEXICO: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 72: MEXICO: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 73: EUROPE: IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 74: EUROPE: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 75: EUROPE: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 76: EUROPE: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 77: EUROPE: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 78: GERMANY: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 79: GERMANY: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 80: GERMANY: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 81: GERMANY: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 82: FRANCE: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 83: FRANCE: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 84: FRANCE: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 85: FRANCE: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 86: U.K.: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 87: U.K.: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 88: U.K.: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 89: U.K.: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 90: ITALY: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 91: ITALY: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 92: ITALY: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 93: ITALY: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 94: SPAIN: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 95: SPAIN: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 96: SPAIN: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 97: SPAIN: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 98: ROE: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 99: ROE: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 100: ROE: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 101: ROE: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 102: ASIA: IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 103: ASIA: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 104: ASIA: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 105: ASIA: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 106: ASIA: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 107: JAPAN: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 108: JAPAN: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 109: JAPAN: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 110: JAPAN: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 111: CHINA: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 112: CHINA: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 113: CHINA: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 114: CHINA: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 115: INDIA: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 116: INDIA: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 117: INDIA: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 118: INDIA: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 119: SOUTH KOREA: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 120: SOUTH KOREA: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 121: SOUTH KOREA: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 122: SOUTH KOREA: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 123: TAIWAN: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 124: TAIWAN: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 125: TAIWAN: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 126: TAIWAN: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 127: ROA: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 128: ROA: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 129: ROA: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 130: ROA: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 131: ROW: IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 132: ROW: IMMUNOASSAY MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 133: ROW: IMMUNOASSAY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 134: ROW: IMMUNOASSAY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 135: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2014-2016
  • TABLE 136: REGULATORY APPROVALS, 2013-2016
  • TABLE 137: EXPANSIONS, 2015-2016
  • TABLE 138: PRODUCT LAUNCHES, 2015-2016
  • TABLE 139: ACQUISITIONS, 2015-2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: IMMUNOASSAY MARKET: BOTTOM-UP APPROACH
  • FIGURE 4: IMMUNOASSAY MARKET: TOP-DOWN APPROACH
  • FIGURE 5: GLOBAL IMMUNOASSAY MARKET: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: REAGENTS AND KITS SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016
  • FIGURE 7: ELISA SEGMENT TO DOMINATE THE IMMUNOASSAY MARKET IN 2016
  • FIGURE 8: INFECTIOUS DISEASES SEGMENT TO DOMINATE THE GLOBAL IMMUNOASSAY MARKET IN 2016
  • FIGURE 9: HOSPITAL SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE IMMUNOASSAY MARKET IN 2016
  • FIGURE 10: ASIA TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 11: RISING INCIDENCES OF CHRONIC & INFECTIOUS DISEASES AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET GROWTH OF THE IMMUNOASSAY MARKET
  • FIGURE 12: REAGENTS & KITS TO COMMAND THE LARGEST MARKET SHARE IN 2016
  • FIGURE 13: ELISA IS EXPECTED TO DOMINATE THE IMMUNOASSAY MARKET IN 2016
  • FIGURE 14: THE U.S. IS EXPECTED TO DOMINATE THE IMMUNOASSAY MARKET IN 2016
  • FIGURE 15: THE INFECTIOUS DISEASES SEGMENT IS POISED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 16: HOSPITALS WILL DOMINATE THE IMMUNOASSAY MARKET BY 2021
  • FIGURE 17: ASIA TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 18: INCIDENCE OF INFECTIOUS DISEASES, PER 100,000 POPULATION IN THE U.S.
  • FIGURE 19: INCIDENCE OF THE TOP TEN CANCERS, PER 100,000 POPULATION, GLOBALLY
  • FIGURE 20: WESTERN BLOT SEGMENT TO HOLD THE FASTEST GROWING MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: REAGENTS & KITS SEGMENT HOLD LARGEST MARKET SHARE IN 2016
  • FIGURE 22: ELISA SEGMENT TO HOLD THE LARGEST MARKET SHARE IN 2016
  • FIGURE 23: THE INFECTIOUS DISEASES APPLICATION SEGMENT IS EXPECTED TO DOMINATE THE IMMUNOASSAY APPLICATIONS MARKET DURING THE FORECAST PERIOD
  • FIGURE 24: GLOBAL CANCER INCIDENCE, BY REGION, 2012 VS. 2015 VS. 2020
  • FIGURE 25: HOSPITALS SEGMENT TO HOLD LARGEST MARKET SHARE IN 2016
  • FIGURE 26: EMERGING ECONOMIES SUCH AS CHINA, INDIA, AND JAPAN OFFER SIGNIFICANT GROWTH OPPORTUNITIES FOR PLAYERS IN THE IMMUNOASSAY MARKET
  • FIGURE 27: NORTH AMERICA: IMMUNOASSAY MARKET SNAPSHOT
  • FIGURE 28: ELISA DOMINATES THE TECHNOLOGY SEGMENT IN THE NORTH AMERICAN MARKET IN 2016
  • FIGURE 29: EUROPE: IMMUNOASSAY MARKET SNAPSHOT
  • FIGURE 30: ASIA: IMMUNOASSAY MARKET SNAPSHOT
  • FIGURE 31: ROW: IMMUNOASSAY MARKET SNAPSHOT
  • FIGURE 32: AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS WAS THE KEY GROWTH STRATEGY ADOPTED BY PLAYERS IN THE IMMUNOASSAY MARKET
  • FIGURE 33: IMMUNOASSAY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 34: BATTLE FOR MARKET SHARE: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS-KEY GROWTH STRATEGY ADOPTED BETWEEN 2014 & 2016
  • FIGURE 35: PRODUCT BENCHMARKING FOR TOP 5 PLAYERS
  • FIGURE 36: F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • FIGURE 37: DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 38: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 39: SIEMENS AG: COMPANY SNAPSHOT
  • FIGURE 40: SYSMEX CORPORATION: COMPANY SNAPSHOT
  • FIGURE 41: BIOMERIEUX SA: COMPANY SNAPSHOT
  • FIGURE 42: ALERE INC.: COMPANY SNAPSHOT
  • FIGURE 43: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 44: ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT
Back to Top